School of Medicine

Projects

Projects per year 2016 2020 2021 2022 2023 2026

• 6 Not started
• 24 Finished
• 31 Active

Projects per year

Search results

• Finished

  The Immediate and Long-term Mental Health Effects of Providing Front-Line Hospital Medical Care During the Coronavirus Pandemic in Kazakhstan

  Foster, F., Sarria-Santamera, A., Stolyarova, V. & Crape, B.

  1/1/21 → 12/31/22

  Project: FDCRGP

  • Kazakhstan 100%
  • Coronavirus 83%
  • Pandemics 70%
  • Mental Health 51%
  • Longitudinal Studies 41%

• Clinico-epidemiological assessment of COVID 19 infection in Kazakhstan

  Colet, P., Sarria-Santamera, A., Abibullaev, B., Zollanvari, A., Azizan, A., Crape, B., Chan, C., Issanov, A., Stitt, N. & Viderman, D.

  1/1/21 → 12/31/22

  Project: FDCRGP

  • Kazakhstan 100%
  • Coronavirus 90%
  • Pandemics 45%
  • SARS Virus 42%
  • severe acute respiratory syndrome 23%

• Epithelial mesenchymal transition mobilizes transposable genetic elements, drives genetic diversity and regulates expression of inflammatory genes in cancer cells

  Tulchinsky, E., Singh, P. & Schoenbach, C.

  1/2/20 → 12/31/22

  Project: FDCRGP

  • neoplasm cells 100%
  • Drug Resistance 57%
  • neoplasms 56%
  • Autophagy 52%
  • genetic variation 40%

• Interpretable artificial intelligence for detection of psychiatric disorders based on multi-modal neuroimaging data

  Lee, M., Fazli, S. & Viderman, D.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • Convolutional neural networks 100%
  • Image classification 85%
  • neural network 76%
  • Cancer Classification 73%
  • X rays 72%

• Development of a diagnostic test for the detection of human antibodies to SARS-CoV-2 (COVID-19)

  Hap Hortelano, G., Schoenbach, C., Ramankulov, E., Burster, T. & Poddighe, D.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • SARS Virus 100%
  • Kazakhstan 56%
  • Severe Acute Respiratory Syndrome 25%
  • Routine Diagnostic Tests 25%
  • Coronavirus 25%

• EPICGuide: EPICGuide: Epidural Catheter Guidance with fiber optic sensors

  Tosi, D., Zollanvari, A., Molardi, C., Viderman, D. & Schena, E.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • Optical Fibers 100%
  • Optical fibers 96%
  • Fiber optics 86%
  • Biosensors 83%
  • Refractive index 68%

• CD-KAZ: Pediatric Celiac Disease in Kazakhstan: epidemiological analysis and implementation of screening and diagnostic strategies.

  Poddighe, D., Tanko, M. N., Sazonov, V., Kozhakhmetova (SSH), A., Marchenko, Y., Abdrakhmanova, S., Catassi, C., Tinelli, C., Teleutayev, Y., Ibrayeva, A., Assylbekova, M., Mukusheva, Z. & Kenzhegulova, R.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • Celiac Disease 100%
  • Pediatrics 26%
  • Kazakhstan 18%
  • Microbiota 17%
  • HLA-DQB1 antigen 12%

• AXL and TYRO3 signaling pathways as therapeutic targets in bladder cancer: preclinical study

  Kriajevskaia, M., Tulchinsky, E. & Ogay, V.

  1/1/20 → 7/4/23

  Project: FDCRGP

  • Urinary Bladder Neoplasms 100%
  • Drug Resistance 47%
  • Kazakhstan 45%
  • Neoplasm Metastasis 32%
  • Neoplasms 23%

• BigDPopH DM: Utilization of large scale administrative health data for population research in Kazakhstan: an application in Diabetes Mellitus

  Sarria-Santamera, A. & Gaipov, A.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • chronic illness 100%
  • Kazakhstan 91%
  • Diabetes Mellitus 66%
  • SDM 34%
  • Type 2 Diabetes Mellitus 30%

• Mental health and help-seeking behaviors of university students in Kazakhstan

  Torrano, D., Clementi, A., Almukhambetova, A., Sparks, J., Lim, N. & Nurtayev, Y. R.

  1/1/20 → 6/30/23

  Project: FDCRGP

  • Kazakhstan 100%
  • mental health 62%
  • university 42%
  • grant 31%
  • student 22%

• Aggregation and utilization of the large-scale administrative health data in Kazakhstan for population health research and surveillance

  Gaipov, A., Kovesdy, C. P., Crape, B., Molnar, M. Z., Alibekova, R., Galiyeva (NUSOM), D., Kadyrzhanuly, K., Potukuchi, P. K. & Issanov, A.

  1/1/20 → 12/31/22

  Project: FDCRGP

  • Kazakhstan 100%
  • Epidemiology 21%
  • Delivery of Health Care 17%
  • Registries 16%
  • Mortality 16%

• Clinicopathologic Features and Immunohistochemical Characteristics of DNA Mismatch Repair Deficient Colorectal Cancer Among Kazakhstani Patients

  Tanko, M. N., Midlenko, A., Ashimkhanova, A., Riethmacher, D. & Riethmacher, E.

  9/1/19 → 9/30/20

  Project: Social Policy

  • Hereditary Nonpolyposis Colorectal Neoplasms 100%
  • Microsatellite Instability 93%
  • Colorectal Neoplasms 24%
  • Turcot syndrome 22%
  • Genetic Profile 19%

• Routes of HIV Transmission in High-Risk Communities of Kazakhstan

  Ali, S.

  1/31/19 → 12/31/21

  Project: FDCRGP

  • Kazakhstan 100%
  • Central Asia 85%
  • HIV 80%
  • Hepatitis B virus 49%
  • Hepatitis B 37%

• Periostin in development and progression of colorectal cancer

  Riethmacher, E., Riethmacher, D. & Ashimkhanova, A.

  1/31/19 → 6/30/22

  Project: FDCRGP

  • Protein Isoforms 100%
  • Colorectal Neoplasms 77%
  • Inflammatory Bowel Diseases 75%
  • Proteins 53%
  • Neoplasms 51%

• A molecular epidemiological study to determine the prevalence of oncogenic HPV strains for cervical cancer prevention in Kazakhstan

  Aimagambetova, G. & Azizan, A.

  1/31/19 → 6/30/22

  Project: FDCRGP

  • Kazakhstan 100%
  • Uterine Cervical Neoplasms 62%
  • Papanicolaou Test 30%
  • Early Detection of Cancer 30%
  • Genotype 30%

• The assessment of Pipelle for endometrial sampling in Kazakhstani settings

  Terzic, M., Linkov, F., Bapayeva, G., Ukybassova, T., Kaiyrlykyzy, A. & Adambekov, S.

  1/31/19 → 6/30/22

  Project: FDCRGP

  • Endometrial Neoplasms 100%
  • Biopsy 82%
  • Dilatation and Curettage 48%
  • Endometriosis 37%
  • Early Detection of Cancer 33%

• DSEN: Diagnosing Children with Special Educational Needs in Kazakhstan

  Pather, S., Somerton, M. I., Stolyarova, V. & Jaxybayeva, A.

  1/31/19 → 12/31/20

  Project: FDCRGP

  • Autistic Disorder 100%
  • Kazakhstan 89%
  • special educational needs 56%
  • Child 36%
  • autism 19%

• An investigation into the anti-microbial and immunomodulatory properties of Kazakhstan honeys in relation to disorders of the skin

  Mcloone, P.

  4/6/18 → 12/31/20

  Project: MES RK

  • Disorder 100%
  • Antimicrobial Agent 81%

• Development of a CCL5-based lead compound for Staphylococcus aureus infection inhibition

  Vangelista, L.

  4/6/18 → 12/31/20

  Project: MES RK

  • Staphylococcus aureus 100%
  • leukotoxin 93%
  • Staphylococcal Infections 88%
  • Lead 61%
  • Anti-Bacterial Agents 38%

• Advancing the State-of the-Art Research and Care for Children with Autism Spectrum Disorder in Kazakhstan

  Foster, F., Chan, C. & An, S.

  4/6/18 → 12/31/20

  Project: MES RK

  • Kazakhstan 100%
  • Child Care 39%
  • Autism Spectrum Disorder 38%
  • Papanicolaou Test 20%
  • Papillomavirus Infections 19%

• A Novel Drug Delivery System for the Treatment of Myocardial Infarction

  Saparov, A.

  4/6/18 → 12/31/20

  Project: MES RK

  • Drug Delivery Systems 100%
  • Myocardial Infarction 73%
  • Education 63%
  • Therapeutics 16%

• Periostin in inflammatory bowel disease (IBD) development and synergistic effects mediated via CCL5 and MMP9.

  Riethmacher, D., Riethmacher, E., Vangelista, L., Ashimkhanova, A., Adrisova, K., Kuatbai, G., Kim , A. K. & Ainur Abdrakhmanova, A.

  1/1/18 → 6/30/21

  Project: FDCRGP

  • Inflammatory Bowel Diseases 100%
  • Inflammatory Bowel Disease 3 83%
  • Inflammation 67%
  • Atopic Dermatitis 63%
  • Proteins 44%

• Non-Mendelian genetics: Regulation of imprinted genes by HP1 proteins

  Singh, P. & Riethmacher, D.

  1/1/18 → 6/1/21

  Project: FDCRGP

  • Embryonic Stem Cells 100%
  • Epigenomics 91%
  • Heterochromatin 76%
  • Cell- and Tissue-Based Therapy 74%
  • Psychological Imprinting 67%

• Extremophiles from unique ecosystems of Kazakhstan as potential producers of novel antimicrobial and anticancer agents

  Azizan, A., Trenozhnikova, L., Berezin, V., Beutler, J., Zhulamanova, A., Koshenov, Z., Iskhakova, D. & Alibekova, M.

  10/1/16 → 12/31/19

  Project: ORAU

  • Kazakhstan 100%
  • Actinobacteria 41%
  • Ecosystem 36%
  • Orthomyxoviridae 33%
  • Cross Infection 33%